Healthcare -
Biotechnology - NASDAQ - US
$ 6.81
-1.59 %
$ 1.01 B
Market Cap
-5.08
P/E
ADPT - REVENUE
Revenue ADPT - Adaptive Biotechnologies Corporation
170 M
LAST VALUE
5.03%
2 YEAR CAGR
25.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR